ESMO 2022 Conference Coverage

 

ESMO 2022 Conference Coverage
Avatar

ESMO 2022 on the JAVELIN Bladder 100 Trial: Avelumab 1L Maintenance for Advanced Urothelial Carcinoma - Results From Patients With ≥12 Months of Treatment

By ESMO 2022 Conference Coverage FEATURING Jeanny Aragon-Ching
By ESMO 2022 Conference Coverage FEATURING Jeanny Aragon-Ching
248 views
October 10, 2022
Comments 0
Login to view comments. Click here to Login
GU
06:54

ESMO 2022 on the JAVELIN Bladder 100 Trial: Avelumab 1L Maintenance …

ESMO 2022 Conference Coverage

J. Aragon-Ching

248 views
05:10

ESMO 2022 on the Results From the PREVAIL Prospective Cohort Study: …

ESMO 2022 Conference Coverage

P. Grivas

148 views
09:42

ESMO 2022 on the Phase 1 Study of PRL-02, a Long-Acting IM Depot Inj…

ESMO 2022 Conference Coverage

J. Avitia

43 views
05:53

ESMO 2022 Initial Results From the Phase 3 SPLASH Study: Efficacy an…

ESMO 2022 Conference Coverage

A. Hansen

280 views
02:47

ESMO 2022 on the Phase 3 VISION Trial: Comparing 177Lu-PSMA-617 Trea…

ESMO 2022 Conference Coverage

A. Armstrong

182 views
05:47

ESMO 2022 on the Impact of TURBT and Intravesical BCG vs. Radical Cy…

ESMO 2022 Conference Coverage

P. Haddad

136 views
04:35

ESMO 2022 on the 4-Factor Model to Predict Response and Survival Ben…

ESMO 2022 Conference Coverage

G. Sonpavde

134 views
12:10

ESMO 2022: Key Bladder Cancer/Urothelial Carcinoma Presentations

ESMO 2022 Conference Coverage

G. Sonpavde

810 views